D3 dopamine receptor agonist (Derexel/Wayne State/New York University)

N/A

Report date: 2025/06/11 10:24:21
NME

Base Information

Drug NameD3 dopamine receptor agonist (Derexel/Wayne State/New York University)
Drug Alias NameD-264D-606SK-609D-440D-512 +[8] 
ClassificationSmall molecules
Mechanisms of ActionNorepinephrine reuptake inhibitorsDopamine D3 receptor agonistsDopamine D2 receptor agonists +[4] 
TargetsDopamine D2 receptorDopamine D3 receptorNorepinephrine transporter
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDrexel University
China Registration ClassN/A

Develop Information

Active CompaniesDrexel UniversityWayne State UniversityNew York University
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A